| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $446K | +87.0% |
| Cost of Revenue | $126K | -37.4% |
| Gross Profit | $321K | +747.4% |
| R&D Expense | $191K | +0.0% |
| SG&A Expense | $6.9M | +16.1% |
| Operating Income | -$10.5M | +6.6% |
| Pre-tax Income | -$15.6M | +2.4% |
| Net Income | -$15.6M | +2.4% |
| EPS (Basic) | -$0.02 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $27K | +58.4% |
| Inventory | $69K | +166.3% |
| Current Assets | $381K | -79.8% |
| Total Assets | $27.7M | -14.9% |
| Current Liabilities | $38.5M | +243.3% |
| Total Liabilities | $38.6M | +18.1% |
| Stockholders' Equity | -$56.9M | -24.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | +33.9% |
| Investing Cash Flow | $121K | +106.6% |
| Financing Cash Flow | $3.7M | -41.0% |
| +0.0% |
| EPS (Diluted) | -$0.02 | +0.0% |